Enfusion (NYSE:ENFN – Get Free Report) and Hitek Global (NASDAQ:HKIT – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.
Institutional and Insider Ownership
81.1% of Enfusion shares are held by institutional investors. Comparatively, 1.2% of Hitek Global shares are held by institutional investors. 39.2% of Enfusion shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Enfusion and Hitek Global’s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Enfusion | $174.54 million | 6.68 | $6.03 million | $0.08 | 113.83 |
Hitek Global | $4.56 million | 3.60 | $1.05 million | N/A | N/A |
Analyst Ratings
This is a summary of recent recommendations and price targets for Enfusion and Hitek Global, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Enfusion | 3 | 2 | 1 | 0 | 1.67 |
Hitek Global | 0 | 0 | 0 | 0 | N/A |
Enfusion currently has a consensus price target of $9.33, indicating a potential upside of 2.51%. Given Enfusion’s higher possible upside, equities analysts clearly believe Enfusion is more favorable than Hitek Global.
Profitability
This table compares Enfusion and Hitek Global’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Enfusion | 3.45% | 10.30% | 7.78% |
Hitek Global | N/A | N/A | N/A |
Summary
Enfusion beats Hitek Global on 10 of the 10 factors compared between the two stocks.
About Enfusion
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.
About Hitek Global
Hitek Global Inc. provides information technology (IT) consulting and solutions to small and medium businesses in various industry sectors in China. It offers anti-counterfeiting tax control system (ACTCS) tax devices, including golden tax disk and printers, ACTCS services, and IT services; and sells software and hardware to large businesses, such as laptops, printers, desktop computers, and related accessories, as well as Internet servers, cameras, and monitors. The company was founded in 1996 and is headquartered in Xiamen, China.
Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.